Clinical Trials Logo

Filter by:
NCT ID: NCT03539965 Completed - Clinical trials for Triple Negative Breast Cancer

Triple-negative Breast Cancer: a New Perspective on Biomarkers

TNBCbrazil
Start date: January 1, 2010
Phase:
Study type: Observational

A single-institutional cohort to determine the prevalence of new immunohistochemical panel in advanced triple-negative submitted to neoadjuvant chemotherapy and its association with response and survival.

NCT ID: NCT03539952 Completed - Wilson Disease Clinical Trials

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Start date: September 3, 2018
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)

NCT ID: NCT03538873 Completed - Clinical trials for Subsyndromic Symptoms of Depression

"Prevention and Treatment of Depression in the Elderly: A Population-Based Study"

Start date: November 13, 2013
Phase: N/A
Study type: Interventional

Considering the rapid increase of the elderly population in Brazil and the growing impact of depression, the third cause of global burden of diseases in the world, the relevance of depression prevention and treatment in older people tend to raise in future years. The investigators planned to screen 2,700 individuals, 60 years and older, from Basic Health Units in the west region of Sao Paulo city, for subsyndromic depressive and / or anxiety symptoms. The elderly will be assessed with a standardized psychiatric interview to calculate the prevalence of subsyndromic symptoms of depression and / or anxiety and the prevalence of depressive and anxiety disorders. Those who do not meet criteria for depressive disorders and / or anxiety will be invited to participate in a randomized clinical trial with 2 arms: a stepped-care prevention program with physical activity (n = 35) or usual care (n = 35). The primary outcome measure will be the cumulative incidence of major depressive disorder, or anxiety disorders, after 12 months.

NCT ID: NCT03537664 Completed - Clinical trials for Bacterial Infections

Adjunctive Steps for Disinfection of Teeth With Primary Endodontic Infections

Start date: August 4, 2017
Phase: N/A
Study type: Interventional

This study aims to evaluate an endodontic treatment protocol using adjunctive steps for disinfection of teeth with primary endodontic infections.

NCT ID: NCT03535610 Completed - Uterine Leiomyoma Clinical Trials

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

EMBOSOFT I
Start date: August 13, 2018
Phase: N/A
Study type: Interventional

To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

NCT ID: NCT03532672 Completed - Healthy Clinical Trials

Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without Obesity

Start date: September 22, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of overnight fasting versus a diurnal fasting (during daily life activities) in females with and without obesity on inflammation, neurotrophins, energy metabolism, mood, food cravings, and appetite sensations. This study will be an acute fasting intervention.

NCT ID: NCT03532659 Completed - Physical Activity Clinical Trials

Impact of Active Video Game on Cardiorespiratory, Macro and Microcirculation Function of Adolescents With Overweight

Start date: July 2, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effects of physical exercise through active videogame in the microcirculation, macrocirculation, cardiorespiratory function and physical fitness in overweight adolescents. For that, they will be randomized into two groups, one being a control group and the other intervention group. The randomization will be made by school. The intervention group will perform the physical exercise through the active video game, three times a week, for 50 minutes, during 8 weeks. Reassessments will be performed before and after the intervention to evaluate the outcome variables.

NCT ID: NCT03531541 Completed - Pain Clinical Trials

Hypoalgesic Effect of Electrical Current and Cervical Manipulation

Start date: May 10, 2018
Phase: N/A
Study type: Interventional

This study evaluates the hypoalgesic effect of the TENS application associated with joint manipulation of the cervical region in healthy individuals. One group had both active treatments, the other group received both placebo treatments, the third and fourth group received only one of the two treatments actively and the other placebo

NCT ID: NCT03531034 Completed - Exercise Clinical Trials

Ambulatory and Blood Pressure Variability Responses to Exercise in Normotensive and Hypertensive Women

Start date: March 1, 2014
Phase: N/A
Study type: Interventional

This study evaluated the differences between normotensive and hypertensive menopausal women in ambulatory and blood pressure variability responses to combined aerobic and resistance exercise.

NCT ID: NCT03529786 Completed - Clinical trials for Mucopolysaccharidosis II

Mucopolysaccharidosis Type II Natural History

Start date: September 27, 2017
Phase:
Study type: Observational

Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is caused by a deficiency of iduronate-2-sulfatase (IDS) leading to an accumulation of glycosaminoglycans (GAGs) in tissues of MPS II patients, resulting in characteristic storage lesions and diverse disease sequelae, and in patients with the more severe form of the disease, irreversible neurocognitive decline and higher morbidity and mortality than in patients with the attenuated form of the disease. There is currently limited information on the natural history of MPS II, especially with respect to neurocognitive decline in patients with the more severe form of the disease. This study is planned to be an observational medical records review study (data collected retrospectively and no investigational product treatment or procedures) in subjects with the severe form of MPS II. Collectively, the data may inform the design of future MPS II gene therapy treatment studies and may be utilized as historical comparative control data.